For Sponsors & CROs
Your Trials. Our Community Reach.
Your Trials. Our Community Reach.
At Orizzonte, we offer sponsors and CROs a new way to run clinical trials faster, more representative, and rooted in patient trust. By delivering research through GP practices across the UK, we help you reach real-world patients where they already receive care.
What We Offer
Real-World Feasibility
Patient population insights directly from GP systems, ensuring the right patients, right sites, and right conditions.
End-to-End Trial Delivery
In-person, hybrid, and decentralised visit support across primary care settings, fully integrated with sponsor CTMS and EDC systems.
Local Trial Teams
Research-trained GPs, dedicated study coordinators, and experienced research nurses supporting every site.
Decentralised Trial Support
Flexible visit models with options for home visits, virtual appointments, and remote monitoring.
What We Offer
Real-World Feasibility
Patient population insights directly from GP systems, ensuring the right patients, right sites, and right conditions.
End-to-End Trial Delivery
In-person, hybrid, and decentralised visit support across primary care settings, fully integrated with sponsor CTMS and EDC systems.
Local Trial Teams
Research-trained GPs, dedicated study coordinators, and experienced research nurses supporting every site.
Decentralised Trial Support
Flexible visit models with options for home visits, virtual appointments, and remote monitoring.
Accelerated Recruitment
Improved Retention
Increased Diversity & Inclusion
Regulatory Confidence
Operational Efficiency
Why Partner with Orizzonte
Accelerated Recruitment
Improved Retention
Increased Diversity & Inclusion
Regulatory Confidence
Operational Efficiency
Empowering clinicians to become research-active is not just about advancing science — it’s about transforming care at its core
Dr. Aries Maximus Ogbuokiri
COO
Empowering clinicians to become research-active is not just about advancing science — it’s about transforming care at its core
Dr. Aries Maximus Ogbuokiri
COO
Latest News & Articles
Artificial Intelligence and the Transformation of Clinical Trials
The Diversity Dilemma: Why Representation in Clinical Trials Is Non-Negotiable
Decentralized Clinical Trials: Redefining Research in a Digitally Connected World
Connect with our leaders
Dr. Zuhaib Keekeebhai
Lead Principal Investigator – Primary Care Trials
Dr Gillian Hood
Diabetes Research Manager at Barts & the London School of Medicine and Dentistry, Queen Mary, University of London
Akash Patel
Consultant Trauma and Orthopaedic Surgeon at RoyalFreeLondonNHSFoundation Trust and Associate professor at University College London
Who we work with
Pharmaceuticals
Hospitals
Academia
Who we work with
Pharmaceuticals
Hospitals
Academia
Why It Matters
Reduced Trial Delays
Evidence-based site selection helps avoid underperforming sites and recruitment shortfalls.
Real-World Representation
Our network includes practices in urban, rural, and underserved regions—ensuring diversity in study populations.
Sponsor Confidence
Data-driven feasibility and operational readiness give sponsors the insight they need for confident site selection.
